C4.4A highly expressed in HER2-positive human breast cancers may indicate a good prognosis
Authors:
- 6 August 2013
- journal article
- research article
- Published by Springer Nature in Breast Cancer
- Vol. 22 (4) , 366-373
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011Annals of Oncology, 2011
- Development of 95-gene classifier as a powerful predictor of recurrences in node-negative and ER-positive breast cancer patientsBreast Cancer Research and Treatment, 2010
- Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assaysThe Breast, 2009
- Reversibility of Epithelial-Mesenchymal Transition (EMT) Induced in Breast Cancer Cells by Activation of Urokinase Receptor-dependent Cell SignalingJournal of Biological Chemistry, 2009
- Altered expression of the urokinase receptor homologue, C4.4A, in invasive areas of human esophageal squamous cell carcinomaInternational Journal of Cancer, 2007
- Tumour cell expression of C4.4A, a structural homologue of the urokinase receptor, correlates with poor prognosis in non-small cell lung cancerLung Cancer, 2007
- Epithelial—mesenchymal and mesenchymal—epithelial transitions in carcinoma progressionJournal of Cellular Physiology, 2007
- hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycanBritish Journal of Cancer, 2003
- Upregulation of C4.4 A Expression During Progression of MelanomaJournal of Investigative Dermatology, 2001
- Cloning and functional characterization of a new phosphatidyl-inositol anchored molecule of a metastasizing rat pancreatic tumorOncogene, 1998